country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-165375

Copy Link Print Information

Plenolin

Plenolin is an anticancer agent. Plenolin exhibits inhibitory activity against human epidermoid carcinoma cells. Plenolin shows in vivo antitumor activity against ascites carcinosarcoma and lymphocytic leukemia in rodent models. Plenolin can be used for research related to ascites tumors and leukemia.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 34257-95-9
Formel: C₁₅H₂₀O₄
Molecular Weight:264.32

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Plenolin Chemical Structure

CAS. Nr.: 34257-95-9

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Protokoll (1)
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Cellular Effect

Cell Line	Type	Value	Description	References
HEp-2	ED₅₀	0.81 μg/mL Compound: 12	Cytotoxicity against human Hep2 cells assessed as growth inhibition by microtiter method Cytotoxicity against human Hep2 cells assessed as growth inhibition by microtiter method	[PMID: 671468]
HEp-2	ED₅₀	0.814 μg/mL Compound: 3	Cytotoxicity against human Hep2 cells Cytotoxicity against human Hep2 cells	[PMID: 845864]
HepG2	ED₅₀	0.8 μg/mL Compound: 6	Cytotoxicity against human HepG2 cells Cytotoxicity against human HepG2 cells	[PMID: 20187635]

In Vitro

Plenolin (Compound 3) exhibits a cytotoxic ED₅₀ of 0.814 μg/mL against H.Ep.-2 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.

In Vivo

Plenolin (33.3 mg/kg; i.p.; once daily for 7 days) exerts 100.0% inhibitory effect on the growth of Ehrlich ascites carcinoma in male CF₁ mice, completely suppresses ascites accumulation, and the survival rate of treated mice reaches 100% on day 7^[1].
For male rats bearing Walker 256 ascitic carcinosarcoma, the T/C value of mean survival days is 207 when treated with Plenolin at 2.5 mg/kg via i.p. administration^[1].
Plenolin (25 mg/kg; i.p.) results in a T/C value of 134 for mean survival days in male DBA/2 mice inoculated with P388 leukemia^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

CF₁ (male, ~30 g, implanted with 10⁶ Ehrlich ascites carcinoma cells)^[1]
Dosage:

33.3 mg/kg/day
Administration:

i.p.; daily
Result:

Achieved 100.0% inhibition of tumor growth.
Reduced ascites-crit to 0.
Reduced total ascites fluid volume to 0.0 mL.
Ensured 100% survival of 5 treated mice to day 7.

Chemical Information

CAS. Nr. 34257-95-9
Molecular Weight 264.32
Formel C₁₅H₂₀O₄
SMILES

C[C@@]12[C@]([C@H](C)C[C@@]3([C@]([C@@H]1O)([C@H](C)C(=O)O3)[H])[H])(C=CC2=O)[H]
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Protokoll

All Animals and Diseases

Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Hall IH, et al. Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones. J Med Chem. 1977;20(3):333-337. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen